These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36517252)

  • 1. The Protective Effect of Social Reward on Opioid and Psychostimulant Reward and Relapse: Behavior, Pharmacology, and Brain Regions.
    Venniro M; Marino RAM; Chow JJ; Caprioli D; Epstein DH; Ramsey LA; Shaham Y
    J Neurosci; 2022 Dec; 42(50):9298-9314. PubMed ID: 36517252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling.
    Hearing M; Graziane N; Dong Y; Thomas MJ
    Trends Pharmacol Sci; 2018 Mar; 39(3):276-294. PubMed ID: 29338873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal Models of (or for) Aggression Reward, Addiction, and Relapse: Behavior and Circuits.
    Golden SA; Jin M; Shaham Y
    J Neurosci; 2019 May; 39(21):3996-4008. PubMed ID: 30833504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of social stress in addiction to psychostimulants: what we know from animal models.
    Aguilar MA; García-Pardo MP; Montagud-Romero S; Miñarro J; Do Couto BR
    Curr Pharm Des; 2013; 19(40):7009-25. PubMed ID: 23574439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.
    Xi ZX; Gardner EL
    Curr Drug Abuse Rev; 2008 Nov; 1(3):303-27. PubMed ID: 19430578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serotonin 5-HT1B receptors in psychostimulant addiction.
    Miszkiel J; Filip M; Przegaliński E
    Pharmacol Rep; 2011; 63(6):1310-5. PubMed ID: 22358079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse to opioid seeking in rat models: behavior, pharmacology and circuits.
    Reiner DJ; Fredriksson I; Lofaro OM; Bossert JM; Shaham Y
    Neuropsychopharmacology; 2019 Feb; 44(3):465-477. PubMed ID: 30293087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immediate early genes in brain reward circuitries: Differential regulation by psychostimulant and opioid drugs.
    Bisagno V; Cadet JL
    Neurochem Int; 2019 Mar; 124():10-18. PubMed ID: 30557593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.
    Bailey CP; Husbands SM
    Expert Opin Drug Discov; 2014 Nov; 9(11):1333-44. PubMed ID: 25253272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review.
    Karimi-Haghighi S; Chavoshinezhad S; Mozafari R; Noorbakhsh F; Borhani-Haghighi A; Haghparast A
    Cell Mol Neurobiol; 2023 Mar; 43(2):649-682. PubMed ID: 35461410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An operant social self-administration and choice model in rats.
    Venniro M; Shaham Y
    Nat Protoc; 2020 Apr; 15(4):1542-1559. PubMed ID: 32203485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operant Social Reward Decreases Incubation of Heroin Craving in Male and Female Rats.
    Venniro M; Russell TI; Zhang M; Shaham Y
    Biol Psychiatry; 2019 Dec; 86(11):848-856. PubMed ID: 31326085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review.
    Lu L; Shepard JD; Hall FS; Shaham Y
    Neurosci Biobehav Rev; 2003 Aug; 27(5):457-91. PubMed ID: 14505687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Influences in Animal Models of Opiate Addiction.
    Tomek SE; Olive MF
    Int Rev Neurobiol; 2018; 140():81-107. PubMed ID: 30193710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amygdala mechanisms of Pavlovian psychostimulant conditioning and relapse.
    Buffalari DM; See RE
    Curr Top Behav Neurosci; 2010; 3():73-99. PubMed ID: 21161750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
    Everett N; Baracz S; Cornish J
    Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volitional social interaction prevents drug addiction in rat models.
    Venniro M; Zhang M; Caprioli D; Hoots JK; Golden SA; Heins C; Morales M; Epstein DH; Shaham Y
    Nat Neurosci; 2018 Nov; 21(11):1520-1529. PubMed ID: 30323276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving translation of animal models of addiction and relapse by reverse translation.
    Venniro M; Banks ML; Heilig M; Epstein DH; Shaham Y
    Nat Rev Neurosci; 2020 Nov; 21(11):625-643. PubMed ID: 33024318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAAR1 and Psychostimulant Addiction.
    Liu J; Wu R; Li JX
    Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.